Today is May 07, 2024. All times in Eastern Daylight Time.
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
04/15/2024 - 04:05 PM
BUSINESS WIRE
Zeta to Announce First Quarter 2024 Results on May 6, 2024
04/15/2024 - 04:05 PM
BUSINESS WIRE
ENERPLUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enerplus Corporation - ERF
04/15/2024 - 04:02 PM
BUSINESS WIRE
ATSG to Host First Quarter 2024 Investor Conference Call
04/15/2024 - 04:01 PM
BUSINESS WIRE
ClearBridge Investments Sends Letter Urging Board of Directors of Model N, Inc. to Reconsider Proposed Acquisition by Vista Equity Partners
04/15/2024 - 04:00 PM
BUSINESS WIRE
OFS Credit Company Provides March 2024 Net Asset Value Update
04/15/2024 - 04:00 PM
BUSINESS WIRE
ZTS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Zoetis Inc. (NYSE: ZTS) Investors with Losses to Contact the Firm
04/15/2024 - 03:51 PM
BUSINESS WIRE
GL Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Globe Life Inc. (GL) Investors to Contact the Firm
04/15/2024 - 03:43 PM
BUSINESS WIRE
NXPL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of NextPlat Corp Is Fair to Shareholders
04/15/2024 - 03:43 PM
BUSINESS WIRE
UKG Named One of the World’s Most Innovative Companies by Fast Company
04/15/2024 - 03:42 PM
BUSINESS WIRE
1
...
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
...
1675
« Previous
Next »